세계의 유방 병변 국소화 시장

Global Breast Lesion Localization Market to Reach US$430.2 Million by 2030

The global market for Breast Lesion Localization estimated at US$315.8 Million in the year 2023, is expected to reach US$430.2 Million by 2030, growing at a CAGR of 4.5% over the analysis period 2023-2030. Breast Biopsy, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$309.2 Million by the end of the analysis period. Growth in the Lumpectomy segment is estimated at 3.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$85.8 Million While China is Forecast to Grow at 4.2% CAGR

The Breast Lesion Localization market in the U.S. is estimated at US$85.8 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$67.8 Million by the year 2030 trailing a CAGR of 4.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.3% and 3.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global Breast Lesion Localization Market - Key Trends and Drivers Summarized

Why Is Breast Lesion Localization Critical in Modern Medicine?

Breast lesion localization is a vital step in the management of breast cancer, especially for early detection and treatment planning. But what does this procedure entail? Essentially, it involves marking suspicious areas within the breast tissue to guide surgeons during biopsy or surgery. As breast cancer rates rise globally, the importance of accurate localization methods has only increased. Traditional methods such as wire localization, where a wire is inserted to mark the lesion, have been used for decades but are being phased out in favor of more advanced techniques. These new approaches offer higher precision, less discomfort, and more effective targeting of smaller or non-palpable lesions, greatly enhancing patient outcomes. With evolving technologies like ultrasound, mammography, and magnetic resonance imaging (MRI) guiding these procedures, the medical community is better equipped than ever to perform targeted interventions, minimizing damage to surrounding tissues and improving recovery rates.

What Are The Advancements in Breast Lesion Localization Technology?

In recent years, breast lesion localization technologies have undergone significant evolution. Historically, wire-guided localization (WGL) was the gold standard. However, non-wire alternatives like radar localization, radiofrequency identification (RFID), and magnetic seeds have emerged, offering more streamlined and efficient procedures. For instance, radar localization uses radar waves to precisely target lesions without the discomfort or limitations associated with wires. RFID tags, which involve implanting a small tag into the lesion, allow for more flexible scheduling as they can remain in place for longer periods. Magnetic seed localization, another innovative method, involves inserting a small magnetic seed into the lesion, which can then be easily detected during surgery. These technologies are especially beneficial for patients with non-palpable lesions, reducing the need for repeated surgeries due to mislocalization and enhancing both the patient's experience and the physician’s accuracy. The shift toward minimally invasive, highly accurate techniques underscores a broader trend in personalized medicine, where precision and patient comfort are paramount.

How Are Changing Guidelines and Patient Needs Shaping Breast Lesion Localization?

The clinical landscape for breast lesion localization has been shaped by several key trends, including updated medical guidelines and changing patient expectations. Guidelines from organizations like the American Society of Breast Surgeons (ASBrS) emphasize the need for localized excision with minimal margins, which directly impacts the choice of localization methods. Surgeons are increasingly seeking techniques that provide real-time feedback, enhance accuracy, and ensure a high degree of confidence in the excision of malignant tissue. Patient-centric care has also emerged as a defining factor, as patients seek minimally invasive options that reduce anxiety and procedural discomfort. The demand for more flexible scheduling and reduced time between diagnosis and surgery has spurred the adoption of technologies that eliminate the constraints imposed by traditional wire-guided localization, where timing was critical to ensure wire stability. As a result, non-wire localization methods, which can be implanted days before surgery, provide more convenience and peace of mind for both patients and healthcare providers.

What Are The Key Growth Drivers In The Breast Lesion Localization Market?

The growth in the breast lesion localization market is driven by several factors, reflecting the increasing demand for more advanced, patient-friendly technologies. First, technological advancements in non-wire localization methods, such as RFID, magnetic seeds, and radar, have improved both accuracy and patient comfort, pushing healthcare facilities to adopt these innovations. Second, the rising incidence of breast cancer globally has led to a greater need for precise localization techniques as part of early detection and treatment strategies. Third, evolving healthcare policies and the increasing focus on value-based care have encouraged hospitals to invest in technologies that offer better outcomes with fewer complications, aligning with modern medical reimbursement models. Additionally, the aging population and increased breast cancer screening rates in developing countries are creating new opportunities for market expansion. Lastly, patient preferences for minimally invasive procedures and technologies that allow for more flexible scheduling have accelerated the shift away from wire-guided methods, further driving the demand for innovative breast lesion localization solutions. Together, these factors are transforming the landscape of breast lesion localization, fostering a market that prioritizes technological advancements, patient experience, and improved clinical outcomes.

Select Competitors (Total 43 Featured) -

• Argon Medical Devices, Inc.
• BARD, A Becton, Dickinson Company
• Cianna Medical, Inc.
• Cook Medical LLC
• CP Medical Corporation
• Somatex Medical Technologies GmbH
• Sterylab Srl

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Breast Lesion Localization - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Breast Cancer Globally Drives Demand for Accurate and Efficient Localization Technologies
  • Advancements in Non-Wire Localization Techniques Propel Growth in Breast Lesion Localization Market
  • Increased Adoption of Radiofrequency Identification (RFID) and Magnetic Seed Localization Expands Addressable Market Opportunities
  • Adoption of Image-Guided Localization Techniques Accelerates Market Growth
  • Growing Focus on Reducing Re-Excision Rates and Improving Surgical Outcomes Propels Demand for Advanced Localization Tools
  • Surge in Demand for Targeted Breast Surgeries and Personalized Treatment Plans Drives Adoption of Localization Technologies
  • Here's How Advances in Magnetic Seed and Radar Localization Techniques are Creating New Market Opportunities
  • Increased Awareness of Breast Cancer Screening Programs Globally Generates New Opportunities for Localization Technologies
  • Rising Adoption of RFID Localization in Complex Breast Surgeries Spurs Technological Innovation
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Breast Lesion Localization Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Breast Lesion Localization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 3: World 7-Year Perspective for Breast Lesion Localization by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Breast Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 5: World 7-Year Perspective for Breast Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • TABLE 6: World Recent Past, Current & Future Analysis for Lumpectomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 7: World 7-Year Perspective for Lumpectomy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Wire Localization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 9: World 7-Year Perspective for Wire Localization by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Magnetic Localization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 11: World 7-Year Perspective for Magnetic Localization by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • TABLE 12: World Recent Past, Current & Future Analysis for Radioisotope Localization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 13: World 7-Year Perspective for Radioisotope Localization by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Other Method Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 15: World 7-Year Perspective for Other Method Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Breast Lesion Localization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 16: USA Recent Past, Current & Future Analysis for Breast Lesion Localization by Usage - Breast Biopsy and Lumpectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 17: USA 7-Year Perspective for Breast Lesion Localization by Usage - Percentage Breakdown of Value Sales for Breast Biopsy and Lumpectomy for the Years 2024 & 2030
  • TABLE 18: USA Recent Past, Current & Future Analysis for Breast Lesion Localization by Method Type - Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 19: USA 7-Year Perspective for Breast Lesion Localization by Method Type - Percentage Breakdown of Value Sales for Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types for the Years 2024 & 2030
• CANADA
  • TABLE 20: Canada Recent Past, Current & Future Analysis for Breast Lesion Localization by Usage - Breast Biopsy and Lumpectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 21: Canada 7-Year Perspective for Breast Lesion Localization by Usage - Percentage Breakdown of Value Sales for Breast Biopsy and Lumpectomy for the Years 2024 & 2030
  • TABLE 22: Canada Recent Past, Current & Future Analysis for Breast Lesion Localization by Method Type - Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 23: Canada 7-Year Perspective for Breast Lesion Localization by Method Type - Percentage Breakdown of Value Sales for Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types for the Years 2024 & 2030
• JAPAN
  • Breast Lesion Localization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 24: Japan Recent Past, Current & Future Analysis for Breast Lesion Localization by Usage - Breast Biopsy and Lumpectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 25: Japan 7-Year Perspective for Breast Lesion Localization by Usage - Percentage Breakdown of Value Sales for Breast Biopsy and Lumpectomy for the Years 2024 & 2030
  • TABLE 26: Japan Recent Past, Current & Future Analysis for Breast Lesion Localization by Method Type - Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 27: Japan 7-Year Perspective for Breast Lesion Localization by Method Type - Percentage Breakdown of Value Sales for Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types for the Years 2024 & 2030
• CHINA
  • Breast Lesion Localization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 28: China Recent Past, Current & Future Analysis for Breast Lesion Localization by Usage - Breast Biopsy and Lumpectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 29: China 7-Year Perspective for Breast Lesion Localization by Usage - Percentage Breakdown of Value Sales for Breast Biopsy and Lumpectomy for the Years 2024 & 2030
  • TABLE 30: China Recent Past, Current & Future Analysis for Breast Lesion Localization by Method Type - Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 31: China 7-Year Perspective for Breast Lesion Localization by Method Type - Percentage Breakdown of Value Sales for Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types for the Years 2024 & 2030
• EUROPE
  • Breast Lesion Localization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 32: Europe Recent Past, Current & Future Analysis for Breast Lesion Localization by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 33: Europe 7-Year Perspective for Breast Lesion Localization by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
  • TABLE 34: Europe Recent Past, Current & Future Analysis for Breast Lesion Localization by Usage - Breast Biopsy and Lumpectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 35: Europe 7-Year Perspective for Breast Lesion Localization by Usage - Percentage Breakdown of Value Sales for Breast Biopsy and Lumpectomy for the Years 2024 & 2030
  • TABLE 36: Europe Recent Past, Current & Future Analysis for Breast Lesion Localization by Method Type - Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 37: Europe 7-Year Perspective for Breast Lesion Localization by Method Type - Percentage Breakdown of Value Sales for Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types for the Years 2024 & 2030
• FRANCE
  • Breast Lesion Localization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 38: France Recent Past, Current & Future Analysis for Breast Lesion Localization by Usage - Breast Biopsy and Lumpectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 39: France 7-Year Perspective for Breast Lesion Localization by Usage - Percentage Breakdown of Value Sales for Breast Biopsy and Lumpectomy for the Years 2024 & 2030
  • TABLE 40: France Recent Past, Current & Future Analysis for Breast Lesion Localization by Method Type - Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 41: France 7-Year Perspective for Breast Lesion Localization by Method Type - Percentage Breakdown of Value Sales for Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types for the Years 2024 & 2030
• GERMANY
  • Breast Lesion Localization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 42: Germany Recent Past, Current & Future Analysis for Breast Lesion Localization by Usage - Breast Biopsy and Lumpectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 43: Germany 7-Year Perspective for Breast Lesion Localization by Usage - Percentage Breakdown of Value Sales for Breast Biopsy and Lumpectomy for the Years 2024 & 2030
  • TABLE 44: Germany Recent Past, Current & Future Analysis for Breast Lesion Localization by Method Type - Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 45: Germany 7-Year Perspective for Breast Lesion Localization by Method Type - Percentage Breakdown of Value Sales for Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types for the Years 2024 & 2030
• ITALY
  • TABLE 46: Italy Recent Past, Current & Future Analysis for Breast Lesion Localization by Usage - Breast Biopsy and Lumpectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 47: Italy 7-Year Perspective for Breast Lesion Localization by Usage - Percentage Breakdown of Value Sales for Breast Biopsy and Lumpectomy for the Years 2024 & 2030
  • TABLE 48: Italy Recent Past, Current & Future Analysis for Breast Lesion Localization by Method Type - Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 49: Italy 7-Year Perspective for Breast Lesion Localization by Method Type - Percentage Breakdown of Value Sales for Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types for the Years 2024 & 2030
• UNITED KINGDOM
  • Breast Lesion Localization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 50: UK Recent Past, Current & Future Analysis for Breast Lesion Localization by Usage - Breast Biopsy and Lumpectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 51: UK 7-Year Perspective for Breast Lesion Localization by Usage - Percentage Breakdown of Value Sales for Breast Biopsy and Lumpectomy for the Years 2024 & 2030
  • TABLE 52: UK Recent Past, Current & Future Analysis for Breast Lesion Localization by Method Type - Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 53: UK 7-Year Perspective for Breast Lesion Localization by Method Type - Percentage Breakdown of Value Sales for Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types for the Years 2024 & 2030
• REST OF EUROPE
  • TABLE 54: Rest of Europe Recent Past, Current & Future Analysis for Breast Lesion Localization by Usage - Breast Biopsy and Lumpectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 55: Rest of Europe 7-Year Perspective for Breast Lesion Localization by Usage - Percentage Breakdown of Value Sales for Breast Biopsy and Lumpectomy for the Years 2024 & 2030
  • TABLE 56: Rest of Europe Recent Past, Current & Future Analysis for Breast Lesion Localization by Method Type - Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 57: Rest of Europe 7-Year Perspective for Breast Lesion Localization by Method Type - Percentage Breakdown of Value Sales for Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types for the Years 2024 & 2030
• ASIA-PACIFIC
  • Breast Lesion Localization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 58: Asia-Pacific Recent Past, Current & Future Analysis for Breast Lesion Localization by Usage - Breast Biopsy and Lumpectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 59: Asia-Pacific 7-Year Perspective for Breast Lesion Localization by Usage - Percentage Breakdown of Value Sales for Breast Biopsy and Lumpectomy for the Years 2024 & 2030
  • TABLE 60: Asia-Pacific Recent Past, Current & Future Analysis for Breast Lesion Localization by Method Type - Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 61: Asia-Pacific 7-Year Perspective for Breast Lesion Localization by Method Type - Percentage Breakdown of Value Sales for Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types for the Years 2024 & 2030
• REST OF WORLD
  • TABLE 62: Rest of World Recent Past, Current & Future Analysis for Breast Lesion Localization by Usage - Breast Biopsy and Lumpectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 63: Rest of World 7-Year Perspective for Breast Lesion Localization by Usage - Percentage Breakdown of Value Sales for Breast Biopsy and Lumpectomy for the Years 2024 & 2030
  • TABLE 64: Rest of World Recent Past, Current & Future Analysis for Breast Lesion Localization by Method Type - Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 65: Rest of World 7-Year Perspective for Breast Lesion Localization by Method Type - Percentage Breakdown of Value Sales for Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types for the Years 2024 & 2030

IV. COMPETITION